{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:54:58Z","timestamp":1779256498400,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.genhosppsych.2025.02.016","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T23:32:56Z","timestamp":1740094376000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Identifying anti-LGI-1 encephalitis in psychotic disorders: A clinically focused review"],"prefix":"10.1016","volume":"94","author":[{"given":"Yujie","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/14737175.2022.2038136","article-title":"Immunopsychiatry: an update on autoimmune encephalitis for neuropsychiatrists","volume":"22","author":"Marques","year":"2022","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.02.016_bb0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.02.016_bb0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0020","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3389\/fneur.2020.00852","article-title":"Clinical characteristics of cognitive impairment and 1-year outcome in patients with anti-LGI1 antibody encephalitis","volume":"11","author":"Hang","year":"2020","journal-title":"Front Neurol"},{"issue":"14","key":"10.1016\/j.genhosppsych.2025.02.016_bb0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0030","article-title":"Clinical features and therapeutic effects of anti-leucine-rich glioma inactivated 1 encephalitis: a systematic review","volume":"12","author":"Teng","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.comppsych.2016.12.006","article-title":"Clinical characterization of autoimmune encephalitis and psychosis","volume":"74","author":"Hao","year":"2017","journal-title":"Compr Psychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.02.016_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4088\/JCP.10l06510","article-title":"Voltage-gated potassium channel\/LGI1 antibody-associated encephalopathy may cause brief psychotic disorder","volume":"72","author":"van Elst","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.02.016_bb0050","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00406-023-01606-w","article-title":"Psychiatric features in NMDAR and LGI1 antibody-associated autoimmune encephalitis","volume":"274","author":"Jia","year":"2024","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.02.016_bb0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/13803395.2019.1617836","article-title":"A 9-year neuropsychological report of a patient with LGI1-associated limbic encephalitis","volume":"41","author":"Zangrandi","year":"2019","journal-title":"J Clin Exp Neuropsychol"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.02.016_bb0060","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/imj.14338","article-title":"A case of anti-leucine-rich glioma-inactivated 1 antibody-mediated limbic encephalitis","volume":"49","author":"Hye","year":"2019","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2169\/internalmedicine.1082-18","article-title":"A patient with limbic encephalitis associated with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody presenting with slowly progressive cognitive impairment and fluctuating striatal lesions","volume":"58","author":"Sato","year":"2019","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2169\/internalmedicine.2963-19","article-title":"Anti-leucine-rich glioma Inactivated-1 encephalitis associated with essential Thrombocythemia","volume":"59","author":"Yuan","year":"2020","journal-title":"Intern Med"},{"issue":"19","key":"10.1016\/j.genhosppsych.2025.02.016_bb0075","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMcpc1100924","article-title":"Case records of the Massachusetts General Hospital. Case 34-2011: a 75-year-old man with memory loss and partial seizures","volume":"365","author":"Cash","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.02.016_bb0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1212\/WNL.0000000000005177","article-title":"Clinical reasoning: a 75-year-old man with parkinsonism, mood depression, and weight loss","volume":"90","author":"Frattini","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0085","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1002\/mus.25572","article-title":"Demyelinating polyneuropathy in a case of anti-LGI1 encephalitis","volume":"56","author":"Tumminelli","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0090","article-title":"Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis","volume":"2017","author":"Pollak","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.02.016_bb0095","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jamaneurol.2014.1234","article-title":"Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex\/leucine-rich, glioma inactivated 1 antibody encephalitis","volume":"71","author":"Naasan","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.02.016_bb0100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1684\/epd.2018.1010","article-title":"Faciobrachial dystonic seizures expressed as epileptic spasms, followed by focal seizures in anti-LGI1 encephalitis: a video-polygraphic study","volume":"20","author":"d'Orsi","year":"2018","journal-title":"Epileptic Disord"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.02.016_bb0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4103\/neuroindia.NI_452_16","article-title":"Faciobrachial dystonic spells: presenting feature of autoimmune encephalopathy","volume":"65","author":"Dubey","year":"2017","journal-title":"Neurol India"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.02.016_bb0110","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.parkreldis.2015.08.014","article-title":"Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis","volume":"21","author":"Kurtis","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/WNL.0b013e31825f0522","article-title":"Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis","volume":"79","author":"Tofaris","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.02.016_bb0120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1039856218771513","article-title":"LGI1 antibody encephalitis and psychosis","volume":"26","author":"Wang","year":"2018","journal-title":"Australas Psychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.02.016_bb0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/nan.12132","article-title":"LGI1 autoantibodies associated with cerebellar degeneration","volume":"40","author":"Steriade","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5144\/0256-4947.2015.76","article-title":"Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies","volume":"35","author":"Messelmani","year":"2015","journal-title":"Ann Saudi Med"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2025.02.016_bb0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2014.03.012","article-title":"Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis","volume":"271","author":"Brown","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2025.02.016_bb0140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.05.048","article-title":"Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy","volume":"343","author":"Szots","year":"2014","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.02.016_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-228428","article-title":"Rapidly progressive global cerebral atrophy in the setting of anti-LGI1 encephalitis","volume":"12","author":"Yelam","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.seizure.2019.01.013","article-title":"Sudden cardiac death in a patient with LGI1 antibody-associated encephalitis","volume":"65","author":"Rizzi","year":"2019","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.02.016_bb0155","first-page":"646","article-title":"Leucine-rich glioma inactivated-1 protein antibody associated limbic encephalitis: one case report","volume":"46","author":"Zheng","year":"2014","journal-title":"Beijing Da Xue Xue Bao"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.comppsych.2017.11.002","article-title":"LGI1 antibody encephalitis - detailed clinical, laboratory and radiological description of 13 cases in China","volume":"81","author":"Wang","year":"2018","journal-title":"Compr Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2025.02.016_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0170","article-title":"Anti-LGI1 encephalitis preceded by psychiatric symptoms: a case report","volume":"3","author":"Numazawa","year":"2024","journal-title":"PCN Rep"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1168302","article-title":"Anti-leucine-rich glioma-inactivated 1 encephalitis revealed by a manic episode: insights from frontal lobe dysfunction in neuropsychiatry through neuropsychology and metabolic imaging. A case report","volume":"14","author":"Porpiglia","year":"2023","journal-title":"Front Psychiatry"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.02.016_bb0180","article-title":"Anti-LGI1 autoimmune encephalitis in a patient with rheumatoid arthritis and MGUS","volume":"11","author":"Bounou","year":"2024","journal-title":"Eur J Case Rep Intern Med"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.02.016_bb0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/02537176231226191","article-title":"Leucine-rich glioma inactivated 1 (LGI-1) limbic encephalitis presenting with psychotic symptoms without seizures: a case report with five-year follow-up and review of literature","volume":"46","author":"Mamtani","year":"2024","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0190","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2147\/CIA.S380316","article-title":"Confusion and hallucination in a geriatric patient. Pitfalls of a rare differential: case report of an anti-LGI1-encephalitis","volume":"17","author":"Meier","year":"2022","journal-title":"Clin Interv Aging"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.12779\/dnd.2023.22.2.78","article-title":"Anti-LGI1 encephalitis presented with prominent psychosis without loss of consciousness","volume":"22","author":"Cho","year":"2023","journal-title":"Dement Neurocogn Disord"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0200","article-title":"Important clues for the diagnosis of anti-LGI1-antibody autoimmune encephalitis: a case report","volume":"15","author":"Abu-Abaa","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.02.016_bb0205","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/schbul\/sbae155","article-title":"Anti-LGI1 antibody-associated encephalitis misdiagnosed as schizophrenia: a case report","volume":"50","author":"Zhang","year":"2024","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00702-020-02258-z","article-title":"Autoimmune encephalitis with psychiatric features in adults: historical evolution and prospective challenge","volume":"128","author":"Hansen","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.02.016_bb0215","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jnnp.56.6.713","article-title":"Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon","volume":"56","author":"Tsukamoto","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.02.016_bb0220","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.02.016_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060375","article-title":"Psychiatric manifestation of anti-LGI1 encephalitis","volume":"10","author":"Endres","year":"2020","journal-title":"Brain Sci"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.02.016_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103074","article-title":"Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (ab)-mediated encephalitides","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 encephalitis is associated with unique HLA subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.02.016_bb0240","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/hbm.23197","article-title":"Network dynamics during the different stages of hallucinations in schizophrenia","volume":"37","author":"Lefebvre","year":"2016","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0245","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0250","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/mp.2012.181","article-title":"The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations","volume":"19","author":"Amad","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0255","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41398-020-0779-9","article-title":"Deviations in early hippocampus development contribute to visual hallucinations in schizophrenia","volume":"10","author":"Cachia","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.02.016_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1980","article-title":"Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors' cooperation","volume":"11","author":"Gin\u00e9 Serv\u00e9n","year":"2021","journal-title":"Brain Behav"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.02.016_bb0265","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-018-0042-4","article-title":"Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study","volume":"24","author":"Jauhar","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.02.016_bb0270","doi-asserted-by":"crossref","first-page":"e1320","DOI":"10.1212\/WNL.0000000000008934","article-title":"Pathologic tearfulness after limbic encephalitis: a novel disorder and its neural basis","volume":"94","author":"Argyropoulos","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.02.016_bb0275","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00415-023-12051-z","article-title":"Cerebral glucose hypometabolism and hypoperfusion of cingulate gyrus: an imaging biomarker of autoimmune encephalitis with psychiatric symptoms","volume":"271","author":"Sun","year":"2024","journal-title":"J Neurol"},{"issue":"19","key":"10.1016\/j.genhosppsych.2025.02.016_bb0280","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJMra2116304","article-title":"Catatonia","volume":"389","author":"Heckers","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0285","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s42003-022-04084-3","article-title":"Intracranial direct electrical mapping reveals the functional architecture of the human basal ganglia","volume":"5","author":"Qi","year":"2022","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.genhosppsych.2025.02.016_bb0295","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1177\/03635465231172196","article-title":"Clinical relevance and function of anterior Talofibular ligament superior and inferior fascicles: a robotic study","volume":"51","author":"Dalmau-Pastor","year":"2023","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.genhosppsych.2025.02.016_bb0300","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.schres.2020.09.025","article-title":"Brainstem alterations contribute to catatonia in schizophrenia spectrum disorders","volume":"224","author":"Fritze","year":"2020","journal-title":"Schizophr Res"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.02.016_bb0305","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1017\/S0033291722001027","article-title":"Neuropsychiatric phenotypes of anti-NMDAR encephalitis: a prospective study","volume":"53","author":"Espinola-Nadurille","year":"2023","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.02.016_bb0310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.02.016_bb0315","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.sleep.2012.01.002","article-title":"Full recovery of agrypnia associated with anti-Lgi1 antibodies encephalitis under immunomodulatory treatment: a case report with sequential polysomnographic assessment","volume":"13","author":"Peter-Derex","year":"2012","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0320","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12883-018-1099-z","article-title":"Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study","volume":"18","author":"Li","year":"2018","journal-title":"BMC Neurol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.02.016_bb0325","first-page":"320","article-title":"Autoimmune epilepsy and\/or limbic encephalitis can Lead to changes in sleep spindles","volume":"55","author":"Serdaro\u011flu","year":"2018","journal-title":"Noro Psikiyatr Ars"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.02.016_bb0330","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ana.20693","article-title":"Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis","volume":"59","author":"Iranzo","year":"2006","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.02.016_bb0335","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneurol.2011.106","article-title":"Sleep manifestations of voltage-gated potassium channel complex autoimmunity","volume":"68","author":"Cornelius","year":"2011","journal-title":"Arch Neurol"},{"issue":"18","key":"10.1016\/j.genhosppsych.2025.02.016_bb0340","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:01:17Z","timestamp":1744185677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834325000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":68,"alternative-id":["S0163834325000465"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.02.016","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying anti-LGI-1 encephalitis in psychotic disorders: A clinically focused review","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}